News

Comprehensive Study Provides Recommendations for Better Ovarian Cancer Patient Care

March 1, 2022

Key recommendations for improving care of ovarian cancer patients in the United States have been published as part of a collaborative, in-depth initiative spearheaded by the Association of Community Cancer Centers (ACCC) and involving a joint partnership between OCRA, the Society of Gynecologic Oncology, the National Society of Genetic Counselors, and the Association for Molecular Pathology.  The initiative was guided … Continued

Research

New Study Shows Surgical Removal of Fallopian Tubes Can Reduce Ovarian Cancer Risk

February 25, 2022

In promising news on the prevention front, one surgical procedure that leaves the ovaries intact may greatly reduce the risk of ovarian cancer. Recent research findings show that the surgical removal of fallopian tubes in a procedure known as an opportunistic salpingectomy may prevent the most common subtype of ovarian cancer from developing. The procedure … Continued

Research

New Research Shows Cervical Cells May Hold Key to Predicting Ovarian Cancer Risk

February 9, 2022

Cervical cell samples that are routinely collected as part of Pap smears may hold promise for predicting the risk of ovarian and other cancers, according to recent findings published as two separate papers in Nature — one focused on ovarian cancer and the other on breast cancer. The researchers studied cervical samples collected at 15 different health centers in Europe … Continued

Research

OCRA-Funded Research Points to Potential for Predicting Ovarian Cancer

January 14, 2022

New study findings not only reveal where the most common ovarian cancer subtype originates in certain patients, but also point to the future possibility of being able to predict who will get the disease. The research, published in Cell Reports, was led by Clive N. Svendsen, PhD, of Cedars-Sinai Medical Center and OCRA’s Scientific Advisory Committee … Continued

OCRA News

Secondary Cytoreductive Surgery Post-Recurrence Results in Longer Overall Survival

January 5, 2022

A randomized trial recently showed that patients with an ovarian cancer recurrence who undergo cytoreductive surgery along with chemotherapy show better survival rates than those who only receive chemotherapy. More than 400 patients were randomized into two groups: 206 were assigned to cytoreductive debulking surgery and chemotherapy, and 201 only had chemotherapy. The median survival rate in … Continued

Research

OCRA-Funded Study Identifies Antibiotic Found to Kill Tumor Cells Containing BRCA Mutations

June 30, 2021

A long-running study from Dana-Farber Cancer Institute, published in Nature Cancer and co-funded by OCRA, has discovered that the antibiotic novobiocin is capable of targeting and killing tumor cells in laboratory cell lines and tumor models with BRCA1 or BRCA2 genetic mutations–and is effective even in tumors that have become resistant to PARP inhibitors. BRCA1 … Continued

OCRA News

Large Study Suggests Ovarian Cancer Screening in General Public Doesn’t Save Lives

May 17, 2021

Results from a large British clinical trial, which involved more than 200,000 post-menopausal women who were followed for more than 15 years, showed that screening average-risk, asymptomatic women for ovarian cancer does not reduce deaths from the disease. The results were published in the British medical journal, The Lancet.   The trial, called the UK Collaborative Trial of … Continued

Research

OCRA-Funded Research Discoveries in 2020

OCRA-Funded Research Discoveries in 2020

December 17, 2020

It’s hard to believe 2020 is almost over, and what a year it’s been.  Despite the challenges wrought by the pandemic, we’re grateful to report that thanks to your support, OCRA grantees made great strides in ovarian cancer discoveries, bringing us ever closer to improving care and defeating this devastating disease: Revealed two cells of origin for high-grade serous ovarian cancer — … Continued

OCRA News

OCRA-Funded Scientists Further Study Gene Mutation Connected to Ovarian Cancer

November 19, 2020

An international collaborative of scientists, including Dr. Ronald Chandler at Michigan State University, studied ARID1A mutations, which are specific gene mutations observed in deep ovarian and deep infiltrating endometriosis. The authors of the study noted that seeing a high frequency of these mutations in deep ovarian endometriosis supports evidence linking this to endometriosis-associated ovarian cancer. … Continued

OCRA News

The Overview: November 2020

November 18, 2020

We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS TO GIVE

Advocacy

What’s New in Ovarian Cancer Research and Treatment

November 12, 2020

A bright spot in 2020 for the ovarian cancer community has been the ongoing developments in research and treatments. Advances continue to be made, as researchers study the effectiveness of PARP inhibitors as maintenance therapy for ovarian cancer, the most effective way to implement immunotherapy agents, the key factors that can affect the success of … Continued

Research

Watch Expert Presentations from OCRA’s 2020 Virtual National Conference

October 29, 2020

Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts in the field presented on a wide range of topics– demystifying genetic testing and precision medicine, providing resources for financial support, explaining clinical trials, and … Continued

Information